Q&A with CSO Caroline Benn discussing LoQus23's unique approach to Huntington’s disease
Update: 2025-08-05
Description
The latest episode of Optimum Perspectives Podcast has just dropped, featuring LoQus23 Therapeutics’ Chief Scientific Officer and founder Caroline Benn!
Listen as Caroline details the devastating effects of Huntington’s Disease on patients and families, her personal motivations for working in this therapeutic area, as well as LoQus23’s unique approach to battling the disease through their innovative small molecule approach.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel